Microsatellite instability (MSI) as an independent predictor of pathologic complete response (PCR) in locally advanced rectal cancer: A National Cancer Database (NCDB) analysis.

Abstract

616 Background: The relationship between microsatellite instability (MSI) and response to neoadjuvant chemoradiation in rectal cancer is not well understood. We therefore utilized the national cancer database (NCDB) to investigate the association between MSI and pathologic complete response (pCR) in this patient population. Methods: We analyzed 5,086 patients between 2010-2015 with locally advanced rectal cancer who were tested for MSI and treated definitively with chemoradiation followed by surgery. Primary comparison groups were between 4,450 MSI-negative(-) and 636 MSI-positive(+) patients. Multivariable regression analysis was conducted to identify demographic, therapeutic, and clinical characteristics predictive of pCR. Cox proportional hazard ratios were used for survival. Results: All patients were treated with definitive chemoradiation (median dose 50.4 Gy) followed by resection within 4 months. MSI(+) patients were associated with earlier year of diagnosis and higher grade tumors (P < 0.05). The overall pCR rate was 8.6%, including 8.9% for MSI(-) and 5.9% for MSI(+) tumors (P = 0.01). Along with lower T stage, MSI(+) cases were significantly associated with a reduced pCR rate (OR = 0.65, 95% CI 0.43 – 0.96) with multivariable analysis. The 5-year survival for patients with pCR was 93% compared to 73% without it (< 0.001). Conclusions: Microsatellite instability was independently associated with a reduction in pathologic complete response for locally advanced rectal cancer following neoadjuvant chemoradiation in this NCDB-based analysis.[Table: see text]

Management trends and outcomes of breast angiosarcoma: Is breast conservation feasible?

“…Furthermore, we conducted a propensity‐matched analysis for survival between the two main treatments, mastectomy and lumpectomy to account for the indication bias caused by a lack of randomization. Full details of statistical methods have been previously reported …”

Utilization of Stereotactic Ablative Body Radiation Therapy for Intact Renal Cell Carcinoma: Trends in Treatment and Predictors of Outcome

“…The methods of analyzing the National Cancer Database have previously been detailed. 14,15 We searched the database for patients with RCC treated nonsurgically between 2004 and 2016 with SABR directed at the kidney (both of which are coded for in the NCDB) in 1 to 5 fractions and with at least 1 month of follow-up. Full inclusion criteria are outlined in Figure 1.…”

Patterns of care and outcomes in small cell carcinoma of the prostate: A national cancer database analysis

“…We queried the NCDB, which details approximately 70% of cancers diagnosed in the United States, to identify all small cell/neuroendocrine carcinoma cases of the prostate (ICD0‐3 codes: 8574, 8246, 8244, 8240, 8041) between the years 2004 and 2015 in this Institutional Review Board‐exempt study. The methodology involved with NCDB analyses has been previously outlined, as such, a comparable approach was undertaken . Starting from 1 380 357 patients, only 1585 prostate cancer cases (0.1%) were classified as SCC or neuroendocrine carcinoma.…”

“…The methodology involved with NCDB analyses has been previously outlined, as such, a comparable approach was undertaken. 5 Starting from 1 380 357 patients, only 1585 prostate cancer cases (0.1%) were classified as SCC or neuroendocrine carcinoma.…”